NASDAQ : CFLT
$0 (0.0%)
| Source | Headline |
|---|---|
|
Confluent Health Launches The Pain Perspective, Revealing a New National Portrait of Chronic Pain in America
LOUISVILLE, Ky. -- June 16, 2026, June 16, 2026 (GLOBE NEWSWIRE) -- Chronic pain is shaping how millions of Americans live, move, sleep, work, and recover. New findings from Confluent Health suggest the healthcare system may still be falling short in addressing it. globenewswire.com - 2026-06-16 09:00:00 |
|
Confluent Makes It Easier to Build and Secure Real-Time AI at Scale
LONDON--(BUSINESS WIRE)--Confluent, an IBM Company and the data streaming pioneer, today announced new capabilities in Confluent Intelligence and Confluent Cloud that streamline how real-time artificial intelligence (AI) applications are built and secured. These updates remove the security and complexity barriers that stop organizations from moving AI workloads into the real world: Confluent unifies the AI life cycle with tools that developers already live in, integrating Apache Flink® pipeline. businesswire.com - 2026-05-19 05:00:00 |
|
Confluent Medical Technologies Names Tom Testa as Chief Operating Officer
SCOTTSDALE, Ariz., May 01, 2026 (GLOBE NEWSWIRE) -- Confluent Medical Technologies, Inc. (“Confluent”), a leading medical device and materials science contract manufacturer specializing in Nitinol and polymer components, today announced that Tom Testa, has been appointed as Chief Operating Officer ("COO") for the company, effective April 29th, 2026. globenewswire.com - 2026-05-01 12:30:00 |
|
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Confluent, Inc. – CFLT
NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. (“Confluent” or the “Company”) (NASDAQ: CFLT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. globenewswire.com - 2026-04-21 17:16:00 |
|
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Confluent, Inc. - CFLT
NEW YORK, April 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. ("Confluent" or the "Company") (NASDAQ: CFLT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. prnewswire.com - 2026-04-16 10:00:00 |
Sign up for InvestorConsensus.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Last Month
Last Quarter
Last Year
All Time
| Date | Analyst Firm | Action | Previous Grade | New Grade |
|---|---|---|---|---|
| 2026-01-23 | Bernstein | Downgrade | Outperform | Market Perform |
| 2026-01-09 | Citizens | Downgrade | Market Outperform | Market Perform |
| 2025-12-10 | Guggenheim | Downgrade | Buy | Neutral |
| 2025-12-09 | Citigroup | Maintain | Neutral | Neutral |
| 2025-12-09 | Canaccord Genuity | Downgrade | Buy | Hold |
| 2025-12-09 | Baird | Maintain | Neutral | Neutral |
| 2025-12-09 | RBC Capital | Downgrade | Outperform | Sector Perform |
| 2025-12-09 | UBS | Downgrade | Buy | Neutral |
| 2025-12-09 | Oppenheimer | Downgrade | Outperform | Perform |
| 2025-12-09 | Raymond James | Downgrade | Outperform | Market Perform |
| 2025-12-09 | Needham | Downgrade | Buy | Hold |
| 2025-12-09 | DA Davidson | Downgrade | Buy | Neutral |
| 2025-12-08 | Wells Fargo | Downgrade | Overweight | Equal Weight |
| 2025-12-08 | DA Davidson | Maintain | Buy | Buy |
| 2025-12-08 | William Blair | Downgrade | Outperform | Market Perform |
| 2025-10-29 | Canaccord Genuity | Maintain | Buy | Buy |
| 2025-10-28 | Barclays | Maintain | Overweight | Overweight |
| 2025-10-28 | Stephens & Co. | Maintain | Overweight | Overweight |
| 2025-10-28 | Baird | Maintain | Neutral | Neutral |
| 2025-10-28 | Mizuho | Maintain | Outperform | Outperform |
| 2025-10-28 | Truist Securities | Maintain | Buy | Buy |
| 2025-10-28 | Piper Sandler | Maintain | Overweight | Overweight |
| 2025-10-28 | Oppenheimer | Maintain | Outperform | Outperform |
| 2025-10-28 | Goldman Sachs | Maintain | Neutral | Neutral |
| 2025-10-28 | Raymond James | Maintain | Outperform | Outperform |
| 2025-10-28 | Evercore ISI Group | Maintain | Outperform | Outperform |
| 2025-10-28 | RBC Capital | Maintain | Outperform | Outperform |
| 2025-10-28 | UBS | Maintain | Buy | Buy |
| 2025-10-28 | Morgan Stanley | Maintain | Equal Weight | Equal Weight |
| 2025-10-28 | Wells Fargo | Maintain | Overweight | Overweight |
| 2025-10-28 | DA Davidson | Maintain | Buy | Buy |
| 2025-10-28 | Stifel | Maintain | Hold | Hold |
| 2025-10-09 | Citigroup | Maintain | Neutral | Neutral |
| 2025-08-04 | Citigroup | Maintain | Neutral | Neutral |
| 2025-08-01 | Barclays | Maintain | Overweight | Overweight |
| 2025-07-31 | Wells Fargo | Maintain | Overweight | Overweight |
| 2025-07-31 | Stifel | Downgrade | Buy | Hold |
| 2025-07-31 | Piper Sandler | Maintain | Overweight | Overweight |
| 2025-07-31 | Guggenheim | Maintain | Buy | Buy |
| 2025-07-31 | Raymond James | Maintain | Outperform | Outperform |
| 2025-07-31 | Oppenheimer | Maintain | Outperform | Outperform |
| 2025-07-31 | Needham | Maintain | Buy | Buy |
| 2025-07-31 | DA Davidson | Maintain | Buy | Buy |
| 2025-07-31 | RBC Capital | Maintain | Outperform | Outperform |
| 2025-07-31 | UBS | Maintain | Buy | Buy |
| 2025-07-25 | Citigroup | Maintain | Neutral | Neutral |
| 2025-07-21 | Barclays | Maintain | Overweight | Overweight |
| 2025-07-11 | UBS | Maintain | Buy | Buy |
| 2025-05-12 | Citigroup | Maintain | Neutral | Neutral |
| 2025-05-01 | Guggenheim | Maintain | Buy | Buy |
| 2025-05-01 | Needham | Maintain | Buy | Buy |
| 2025-05-01 | Piper Sandler | Maintain | Overweight | Overweight |
| 2025-05-01 | Wells Fargo | Maintain | Overweight | Overweight |
| 2025-05-01 | Truist Securities | Maintain | Buy | Buy |
| 2025-05-01 | DA Davidson | Maintain | Buy | Buy |
| 2025-05-01 | JMP Securities | Maintain | Market Outperform | Market Outperform |
| 2025-05-01 | Barclays | Maintain | Overweight | Overweight |
| 2025-05-01 | TD Securities | Maintain | Buy | Buy |
| 2025-05-01 | Evercore ISI Group | Maintain | Outperform | Outperform |
| 2025-05-01 | Baird | Maintain | Neutral | Neutral |
| 2025-05-01 | Canaccord Genuity | Maintain | Buy | Buy |
| 2025-05-01 | Oppenheimer | Maintain | Outperform | Outperform |
| 2025-05-01 | UBS | Maintain | Buy | Buy |
| 2025-05-01 | Stifel | Maintain | Buy | Buy |
| 2025-04-24 | Scotiabank | Maintain | Sector Perform | Sector Perform |
| 2025-04-23 | Guggenheim | Maintain | Buy | Buy |
| 2025-04-23 | Loop Capital | Maintain | Hold | Hold |
| 2025-04-22 | Wells Fargo | Maintain | Overweight | Overweight |
| 2025-04-21 | Barclays | Maintain | Overweight | Overweight |
| 2025-04-16 | Morgan Stanley | Maintain | Equal Weight | Equal Weight |
| 2025-03-31 | Truist Securities | Maintain | Buy | Buy |
| 2025-03-12 | Citizens Capital Markets | Maintain | Market Outperform | Market Outperform |
| 2025-03-10 | Loop Capital | Maintain | Hold | Hold |
| 2025-03-10 | Citizens Capital Markets | Maintain | Market Outperform | Market Outperform |
| 2025-03-07 | Needham | Maintain | Buy | Buy |
| 2025-02-26 | UBS | Upgrade | Neutral | Buy |
| 2025-02-12 | Barclays | Maintain | Overweight | Overweight |
| 2025-02-12 | Needham | Maintain | Buy | Buy |
| 2025-02-12 | Canaccord Genuity | Maintain | Buy | Buy |
| 2025-02-12 | B of A Securities | Maintain | Underperform | Underperform |
| 2025-02-12 | UBS | Maintain | Neutral | Neutral |
| 2025-02-12 | Guggenheim | Maintain | Buy | Buy |
| 2025-02-12 | Evercore ISI Group | Maintain | Outperform | Outperform |
| 2025-02-12 | Piper Sandler | Maintain | Overweight | Overweight |
| 2025-02-12 | Truist Securities | Maintain | Buy | Buy |
| 2025-02-12 | Scotiabank | Maintain | Sector Perform | Sector Perform |
| 2025-02-12 | Morgan Stanley | Maintain | Equal Weight | Equal Weight |
| 2025-02-12 | Stifel | Maintain | Buy | Buy |
| 2025-02-12 | RBC Capital | Maintain | Outperform | Outperform |
| 2025-02-12 | Wells Fargo | Maintain | Overweight | Overweight |
| 2025-01-31 | Guggenheim | Maintain | Buy | Buy |
| 2025-01-16 | Morgan Stanley | Downgrade | Overweight | Equal Weight |
| 2025-01-06 | Piper Sandler | Maintain | Overweight | Overweight |
| 2025-01-03 | RBC Capital | Maintain | Outperform | Outperform |
| 2024-12-18 | Stifel | Maintain | Buy | Buy |
| 2024-12-13 | Mizuho | Maintain | Outperform | Outperform |
| 2024-12-12 | Truist Securities | Maintain | Buy | Buy |
| 2024-12-11 | JP Morgan | Maintain | Overweight | Overweight |
| 2024-12-06 | Barclays | Maintain | Overweight | Overweight |
| 2024-12-05 | Wells Fargo | Maintain | Overweight | Overweight |
| 2024-11-15 | Needham | Maintain | Buy | Buy |
| 2024-10-31 | Needham | Maintain | Buy | Buy |
| 2024-10-31 | UBS | Maintain | Neutral | Neutral |
| 2024-10-31 | Baird | Maintain | Neutral | Neutral |
| 2024-10-31 | TD Cowen | Maintain | Buy | Buy |
| 2024-10-31 | Barclays | Maintain | Overweight | Overweight |
| 2024-10-31 | Scotiabank | Maintain | Sector Perform | Sector Perform |
| 2024-10-31 | RBC Capital | Maintain | Outperform | Outperform |
| 2024-10-31 | Mizuho | Maintain | Outperform | Outperform |
| 2024-10-29 | Citigroup | Maintain | Neutral | Neutral |
| 2024-10-29 | JMP Securities | Maintain | Market Outperform | Market Outperform |
| 2024-10-25 | JP Morgan | Maintain | Overweight | Overweight |
| 2024-10-25 | Bernstein | Maintain | Outperform | Outperform |
| 2024-10-17 | Mizuho | Maintain | Outperform | Outperform |
| 2024-09-24 | JMP Securities | Maintain | Market Outperform | Market Outperform |
| 2024-09-23 | Needham | Maintain | Buy | Buy |
| 2024-09-20 | TD Cowen | Maintain | Buy | Buy |
| 2024-09-20 | Evercore ISI Group | Maintain | Outperform | Outperform |
| 2024-09-18 | DA Davidson | Maintain | Buy | Buy |
| 2024-08-09 | JP Morgan | Upgrade | Neutral | Overweight |
| 2024-08-01 | Truist Securities | Maintain | Buy | Buy |
| 2024-08-01 | Needham | Maintain | Buy | Buy |
| 2024-08-01 | Stifel | Maintain | Buy | Buy |
| 2024-08-01 | Scotiabank | Maintain | Sector Perform | Sector Perform |
| 2024-08-01 | Piper Sandler | Maintain | Overweight | Overweight |
| 2024-08-01 | DA Davidson | Maintain | Buy | Buy |
| 2024-08-01 | Canaccord Genuity | Maintain | Buy | Buy |
| 2024-08-01 | Deutsche Bank | Maintain | Buy | Buy |
| 2024-08-01 | TD Cowen | Maintain | Buy | Buy |
| 2024-08-01 | Wells Fargo | Maintain | Overweight | Overweight |
| 2024-08-01 | Barclays | Maintain | Overweight | Overweight |
| 2024-08-01 | RBC Capital | Maintain | Outperform | Outperform |
| 2024-08-01 | B of A Securities | Maintain | Underperform | Underperform |
| 2024-07-30 | Citigroup | Maintain | Neutral | Neutral |
| 2024-07-30 | Needham | Maintain | Buy | Buy |
| 2024-07-19 | Loop Capital | Maintain | Hold | Hold |
| 2024-07-16 | Mizuho | Maintain | Outperform | Outperform |
| 2024-06-25 | Guggenheim | Maintain | Buy | Buy |
| 2024-06-11 | Needham | Maintain | Buy | Buy |
| 2024-06-04 | RBC Capital | Maintain | Outperform | Outperform |
| 2024-05-09 | Goldman Sachs | Maintain | Neutral | Neutral |
| 2024-05-08 | Guggenheim | Maintain | Buy | Buy |
| 2024-05-08 | TD Cowen | Maintain | Buy | Buy |
| 2024-05-08 | Canaccord Genuity | Upgrade | Hold | Buy |
| 2024-05-08 | Needham | Maintain | Buy | Buy |
| 2024-05-08 | Barclays | Maintain | Overweight | Overweight |
| 2024-05-08 | Wells Fargo | Maintain | Overweight | Overweight |
| 2024-05-08 | Truist Securities | Maintain | Buy | Buy |
| 2024-05-08 | JMP Securities | Maintain | Market Outperform | Market Outperform |
| 2024-05-08 | RBC Capital | Maintain | Outperform | Outperform |
| 2024-04-15 | Mizuho | Maintain | Buy | Buy |
| 2024-04-01 | DA Davidson | Maintain | Buy | Buy |
| 2024-03-22 | Needham | Maintain | Buy | Buy |
| 2024-02-16 | Mizuho | Maintain | Buy | Buy |
| 2024-02-14 | RBC Capital | Maintain | Outperform | Outperform |
| 2024-02-08 | Scotiabank | Maintain | Sector Perform | Sector Perform |
| 2024-02-08 | Mizuho | Maintain | Buy | Buy |
| 2024-02-08 | JP Morgan | Maintain | Neutral | Neutral |
| 2024-02-08 | Needham | Maintain | Buy | Buy |
| 2024-02-08 | RBC Capital | Maintain | Outperform | Outperform |
| 2024-02-08 | JMP Securities | Maintain | Market Outperform | Market Outperform |
| 2024-02-08 | Wells Fargo | Maintain | Overweight | Overweight |
| 2024-02-08 | Goldman Sachs | Maintain | Neutral | Neutral |
| 2024-02-08 | Barclays | Maintain | Overweight | Overweight |
| 2024-02-05 | UBS | Maintain | Neutral | Neutral |
| 2024-02-01 | Needham | Maintain | Buy | Buy |
| 2024-01-02 | Needham | Maintain | Buy | Buy |
| 2023-11-08 | Capital One | Upgrade | Equal Weight | Overweight |
| 2023-11-03 | Canaccord Genuity | Downgrade | Buy | Hold |
| 2023-11-03 | Guggenheim | Upgrade | Neutral | Buy |
| 2023-11-03 | Wolfe Research | Upgrade | Peer Perform | Outperform |
| 2023-11-03 | Goldman Sachs | Maintain | Neutral | Neutral |
| 2023-11-03 | Truist Securities | Maintain | Buy | Buy |
| 2023-11-03 | JMP Securities | Maintain | Market Outperform | Market Outperform |
| 2023-11-02 | Needham | Maintain | Buy | Buy |
| 2023-11-02 | B of A Securities | Downgrade | Neutral | Underperform |
| 2023-11-02 | Piper Sandler | Maintain | Overweight | Overweight |
| 2023-11-02 | Barclays | Maintain | Overweight | Overweight |
| 2023-11-02 | Canaccord Genuity | Downgrade | Buy | Hold |
| 2023-11-02 | Morgan Stanley | Maintain | Overweight | Overweight |
| 2023-10-12 | Barclays | Maintain | Overweight | Overweight |
| 2023-09-28 | Needham | Maintain | Buy | Buy |
| 2023-09-25 | Needham | Maintain | Buy | Buy |
| 2023-08-03 | Citigroup | Maintain | Neutral | Neutral |
| 2023-08-03 | Morgan Stanley | Maintain | Overweight | Overweight |
| 2023-08-02 | Citigroup | Maintain | Neutral | Neutral |
| 2023-06-23 | Truist Securities | Maintain | Buy | Buy |
| 2023-06-15 | Goldman Sachs | Maintain | Neutral | Neutral |
| 2023-06-15 | Guggenheim | Downgrade | Buy | Neutral |
| 2023-06-14 | Needham | Maintain | Buy | Buy |
| 2023-06-14 | Wells Fargo | Maintain | Overweight | Overweight |
| 2023-06-14 | Mizuho | Maintain | Buy | Buy |
| 2023-06-14 | Guggenheim | Downgrade | Buy | Neutral |
| 2023-06-14 | Barclays | Maintain | Overweight | Overweight |
| 2023-06-14 | JP Morgan | Maintain | Neutral | Neutral |
| 2023-06-14 | Truist Securities | Maintain | Buy | Buy |
| 2023-06-14 | JMP Securities | Maintain | Market Outperform | Market Outperform |
| 2023-06-12 | Needham | Maintain | Buy | Buy |
| 2023-05-31 | Wells Fargo | Maintain | Overweight | Overweight |
| 2023-05-30 | Needham | Maintain | Buy | Buy |
| 2023-05-05 | Goldman Sachs | Maintain | Neutral | Neutral |
| 2023-05-04 | JMP Securities | Maintain | Outperform | Outperform |
| 2023-05-04 | Barclays | Maintain | Overweight | Overweight |
| 2023-05-04 | TD Cowen | Maintain | Outperform | Outperform |
| 2023-05-04 | Goldman Sachs | Maintain | Neutral | Neutral |
| 2023-05-04 | Credit Suisse | Maintain | Outperform | Outperform |
| 2023-05-04 | Wells Fargo | Maintain | Overweight | Overweight |
| 2023-04-28 | Citigroup | Maintain | Neutral | Neutral |
| 2023-04-17 | Barclays | Maintain | Overweight | Overweight |
| 2023-04-12 | Morgan Stanley | Upgrade | Equal Weight | Overweight |
| 2023-03-29 | Mizuho | Maintain | Buy | Buy |
| 2023-03-06 | Credit Suisse | Maintain | Outperform | Outperform |
| 2023-02-01 | Citigroup | Maintain | Neutral | Neutral |
| 2023-01-31 | Barclays | Maintain | Overweight | Overweight |
| 2023-01-31 | Cowen & Co. | Maintain | Outperform | Outperform |
| 2023-01-31 | JMP Securities | Maintain | Market Outperform | Outperform |
| 2023-01-27 | JMP Securities | Maintain | Market Outperform | Market Outperform |
| 2023-01-27 | UBS | Downgrade | Buy | Neutral |
| 2023-01-27 | Guggenheim | Maintain | Buy | Buy |
| 2023-01-24 | UBS | Maintain | Buy | Buy |
| 2023-01-23 | Deutsche Bank | Upgrade | Hold | Buy |
| 2023-01-19 | Cowen & Co. | Maintain | Outperform | Outperform |
| 2023-01-17 | FBN Securities | Maintain | Outperform | Outperform |
| 2023-01-10 | Barclays | Upgrade | Equal Weight | Overweight |
| 2023-01-06 | Wells Fargo | Maintain | Overweight | Overweight |
| 2023-01-06 | Scotiabank | Downgrade | Sector Outperform | Sector Perform |
| 2023-01-05 | Piper Sandler | Maintain | Overweight | Overweight |
| 2022-12-19 | Morgan Stanley | Maintain | Equal Weight | Equal Weight |
| 2022-11-03 | Barclays | Maintain | Equal Weight | Equal Weight |
| 2022-11-03 | JP Morgan | Maintain | Neutral | Neutral |
| 2022-11-03 | Credit Suisse | Maintain | Outperform | Outperform |
| 2022-11-03 | Morgan Stanley | Maintain | Equal Weight | Equal Weight |
| 2022-11-01 | Citigroup | Maintain | Neutral | Neutral |
| 2022-10-20 | Morgan Stanley | Maintain | Equal Weight | Equal Weight |
| 2022-10-18 | Barclays | Maintain | Equal Weight | Equal Weight |
| 2022-09-30 | Truist Securities | Maintain | Buy | Buy |
| 2022-08-04 | Credit Suisse | Maintain | Outperform | Outperform |
| 2022-08-04 | UBS | Maintain | Buy | Buy |
| 2022-08-04 | Wells Fargo | Maintain | Overweight | Overweight |
| 2022-08-04 | Barclays | Maintain | Equal Weight | Equal Weight |
| 2022-08-04 | Morgan Stanley | Maintain | Equal Weight | Equal Weight |
| 2022-07-18 | Barclays | Maintain | Equal Weight | Equal Weight |
| 2022-06-09 | Scotiabank | Maintain | Sector Outperform | Outperform |
| 2022-05-18 | Wells Fargo | Maintain | Overweight | Overweight |
| 2022-05-06 | Credit Suisse | Maintain | Outperform | Outperform |
| 2022-05-06 | Deutsche Bank | Maintain | Hold | Hold |
| 2022-05-06 | Morgan Stanley | Maintain | Equal Weight | Equal Weight |
| 2022-04-19 | Barclays | Maintain | Equal Weight | Equal Weight |
| 2022-04-14 | Goldman Sachs | Maintain | Neutral | Neutral |
| 2022-03-15 | Wells Fargo | Maintain | Overweight | Overweight |
| 2022-02-11 | Credit Suisse | Maintain | Outperform | Outperform |
| 2022-02-11 | Deutsche Bank | Maintain | Hold | Hold |
| 2022-02-11 | Morgan Stanley | Maintain | Equal Weight | Equal Weight |
| 2022-02-01 | Morgan Stanley | Maintain | Equal Weight | Equal Weight |
| 2022-01-26 | Wells Fargo | Maintain | Overweight | Overweight |
| 2022-01-25 | DA Davidson | Upgrade | Neutral | Buy |
| 2021-11-22 | Morgan Stanley | Maintain | Equal Weight | Equal Weight |
| 2021-11-18 | William Blair | Maintain | Outperform | Outperform |
| 2021-11-16 | Credit Suisse | Maintain | Outperform | Outperform |
| 2021-11-05 | JMP Securities | Maintain | Market Outperform | Market Outperform |
| 2021-10-18 | Barclays | Maintain | Equal Weight | Equal Weight |
| 2021-10-12 | Arete Research | Maintain | Buy | Buy |
| 2021-09-15 | DA Davidson | Maintain | Neutral | Neutral |
| 2021-08-16 | Morgan Stanley | Maintain | Equal Weight | Equal Weight |
| 2021-08-06 | JMP Securities | Maintain | Market Outperform | Market Outperform |
| 2021-08-06 | Barclays | Maintain | Equal Weight | Equal Weight |
| 2021-07-20 | Citigroup | Maintain | Neutral | Neutral |